The “Wolverine Stack” of BPC-157 and TB-500 combination brings together two synthetic peptides extensively studied for their potential roles in tissue repair, wound healing, and anti-inflammatory responses. In research settings, this synergistic pairing has been observed to enhance cellular regeneration, promote angiogenesis, and modulate inflammatory pathways. Both peptides are provided in high-purity, lyophilized powder form, ensuring reliability and reproducibility in laboratory experiments.
This research-grade peptide stack combines BPC-157, a 15-amino acid fragment derived from a protective protein in the gastric system, and TB-500, a synthetic version of a segment of thymosin beta-4. Individually, these peptides have been the subject of numerous studies focusing on their regenerative and cytoprotective properties. When used together, they are believed to exhibit complementary actions that may accelerate tissue repair and recovery processes in experimental models.
Structures
BPC-157:
Chemical Formula: C62H98N16O22
TB-500 (Thymosin Beta-4 Fragment):
Chemical Formula: C212H350N56O78S
Applications
For Research Use Only: This peptide combination is intended exclusively for laboratory research purposes, including:
- Investigating cellular repair mechanisms
- Studying anti-inflammatory pathways
- Exploring angiogenesis and tissue regeneration
Potential Synergistic Mechanisms
- BPC-157: Investigated for its potential to enhance tissue regeneration, promote angiogenesis, and exert cytoprotective effects.
- TB-500: Studied for its role in cell migration, anti-inflammatory responses, and facilitation of connective tissue repair.
When combined, these peptides are hypothesized to work synergistically, potentially leading to more efficient and comprehensive tissue repair and recovery in experimental models.
Regulatory and Patent Notice
- Patent Disclaimer: BPC-157 and TB-500 may be subject to patents in certain jurisdictions. Researchers are responsible for ensuring compliance with applicable intellectual property laws.
Frequently Asked Questions (FAQ)
Q: Can this peptide combination be used in human clinical trials?
A: No, BPC-157 and TB-500 are intended solely for laboratory research and are not approved for human clinical use.
Q: How should the peptides be reconstituted for research purposes?
A: Reconstitution should be performed using sterile solvents appropriate for peptide solubility, following standard laboratory protocols.
Q: What is the recommended storage condition for the reconstituted solution?
A: Store the reconstituted peptide solution at 2–8°C and use within 7–14 days to maintain stability.
Reconstitution and dosing
BPC-157 / TB-500 is typically reconstituted with Bacteriostatic water at 5 to 10mg per ml per each peptide. Standard dosing is 250mcg (per each peptide) twice per day up to 1000mcg (per each peptide) twice per day for acute injuries. In wellness cycles, BPC-157 / TB-500 is used in an 8 week on, 8 week off schedule.
An example of reconstitution and dosing for BPC-157 / TB-500 at 5mg each (10mg total) would be 1ml bacteriostatic water dosed at 5 ticks twice a day, resulting in 250mcg each of BPC-157 and TB-500 and a total daily administration of 500mcg each.
BPC-157 / TB-500 10mg vials reconstituted with 2ml water would yield the same dosing protocol as outlined above.
For our free Peptide Calculator CLICK HERE
Disclaimer
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
